Cargando…
Correction: A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719726/ https://www.ncbi.nlm.nih.gov/pubmed/34972194 http://dx.doi.org/10.1371/journal.pone.0262326 |
| _version_ | 1784624998337478656 |
|---|---|
| author | Kim, Stephanie I. Szeto, Andy H. Morgan, Katherine P. Brower, Blaine Dunn, Mary W. Khandani, Amir H. Godley, Paul A. Rose, Tracy L. Basch, Ethan M. Milowsky, Matthew I. Whang, Young E Crona, Daniel J |
| author_facet | Kim, Stephanie I. Szeto, Andy H. Morgan, Katherine P. Brower, Blaine Dunn, Mary W. Khandani, Amir H. Godley, Paul A. Rose, Tracy L. Basch, Ethan M. Milowsky, Matthew I. Whang, Young E Crona, Daniel J |
| author_sort | Kim, Stephanie I. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8719726 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Public Library of Science |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87197262022-01-01 Correction: A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer Kim, Stephanie I. Szeto, Andy H. Morgan, Katherine P. Brower, Blaine Dunn, Mary W. Khandani, Amir H. Godley, Paul A. Rose, Tracy L. Basch, Ethan M. Milowsky, Matthew I. Whang, Young E Crona, Daniel J PLoS One Correction Public Library of Science 2021-12-31 /pmc/articles/PMC8719726/ /pubmed/34972194 http://dx.doi.org/10.1371/journal.pone.0262326 Text en © 2021 Kim et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Correction Kim, Stephanie I. Szeto, Andy H. Morgan, Katherine P. Brower, Blaine Dunn, Mary W. Khandani, Amir H. Godley, Paul A. Rose, Tracy L. Basch, Ethan M. Milowsky, Matthew I. Whang, Young E Crona, Daniel J Correction: A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer |
| title | Correction: A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer |
| title_full | Correction: A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer |
| title_fullStr | Correction: A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer |
| title_full_unstemmed | Correction: A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer |
| title_short | Correction: A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer |
| title_sort | correction: a real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719726/ https://www.ncbi.nlm.nih.gov/pubmed/34972194 http://dx.doi.org/10.1371/journal.pone.0262326 |
| work_keys_str_mv | AT kimstephaniei correctionarealworldevaluationofradium223incombinationwithabirateroneorenzalutamideforthetreatmentofmetastaticcastrationresistantprostatecancer AT szetoandyh correctionarealworldevaluationofradium223incombinationwithabirateroneorenzalutamideforthetreatmentofmetastaticcastrationresistantprostatecancer AT morgankatherinep correctionarealworldevaluationofradium223incombinationwithabirateroneorenzalutamideforthetreatmentofmetastaticcastrationresistantprostatecancer AT browerblaine correctionarealworldevaluationofradium223incombinationwithabirateroneorenzalutamideforthetreatmentofmetastaticcastrationresistantprostatecancer AT dunnmaryw correctionarealworldevaluationofradium223incombinationwithabirateroneorenzalutamideforthetreatmentofmetastaticcastrationresistantprostatecancer AT khandaniamirh correctionarealworldevaluationofradium223incombinationwithabirateroneorenzalutamideforthetreatmentofmetastaticcastrationresistantprostatecancer AT godleypaula correctionarealworldevaluationofradium223incombinationwithabirateroneorenzalutamideforthetreatmentofmetastaticcastrationresistantprostatecancer AT rosetracyl correctionarealworldevaluationofradium223incombinationwithabirateroneorenzalutamideforthetreatmentofmetastaticcastrationresistantprostatecancer AT baschethanm correctionarealworldevaluationofradium223incombinationwithabirateroneorenzalutamideforthetreatmentofmetastaticcastrationresistantprostatecancer AT milowskymatthewi correctionarealworldevaluationofradium223incombinationwithabirateroneorenzalutamideforthetreatmentofmetastaticcastrationresistantprostatecancer AT whangyounge correctionarealworldevaluationofradium223incombinationwithabirateroneorenzalutamideforthetreatmentofmetastaticcastrationresistantprostatecancer AT cronadanielj correctionarealworldevaluationofradium223incombinationwithabirateroneorenzalutamideforthetreatmentofmetastaticcastrationresistantprostatecancer |